<p>(a) Cleavage of caspase-9, caspase-3, PARP (Western blotting), and (b) caspase-3 activation (flow cytometry) in HCT116 wt cells transfected (24 h) with control or PPARγ siRNA, treated (24 h) with rosiglitazone (RGZ, 50 μM) and subsequently incubated (48 h) with LA-12 (0.75 μM). Results are means + S.E.M. of three independent experiments. Statistical significance: P < 0.05, * versus control, ‡ versus RGZ, Ο versus LA-12.</p
<p><b>Copyright information:</b></p><p>Taken from "PPARγ-independent induction of growth arrest and ...
Peroxisome proliferator-activated receptors (PPARs) are shown to modulate the pathological status of...
<div><p>PPARs are nuclear receptors activated by ligands. Activation of PPARγ leads to a reduction o...
<p>Cleavage of caspase-9, caspase-3, PARP and the level of Chk2 and p53 proteins in HCT116 wt, Chk2-...
<p>(a) Percentage of apoptotic (annexin V positive/propidium iodide negative, flow cytometry) HCT116...
<p>(a) Cleavage of PARP, caspase-9 and PTEN level (Western blotting), (b) changes in mitochondrial m...
Peroxisome Proliferator-Activated Receptor gamma (PPARγ) is a ligand-activated transcription factor ...
OBJECTIVE To investigate the anti-proliferative effect of rosiglitazone and its relationship to pero...
Ligands for peroxisome proliferator-activated receptor gamma (PPARγ) possess anticancer properties. ...
<p>(a) The release of cytochrome c into the cytoplasm (cytoplasmic fraction) of HCT116 cells pretrea...
[[abstract]]To determine the involvement of peroxisome proliferator-activated receptor-gamma (PPAR-g...
[[abstract]]Background-Thiazolidinediones have been reported to protect against ischemia-reperfusion...
AIM: To study the effect of rosiglitazone, which is a ligand of peroxisome proliferator-activated re...
Ligands for peroxisome proliferator-activated receptor gamma (PPAR gamma) possess anticancer propert...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
<p><b>Copyright information:</b></p><p>Taken from "PPARγ-independent induction of growth arrest and ...
Peroxisome proliferator-activated receptors (PPARs) are shown to modulate the pathological status of...
<div><p>PPARs are nuclear receptors activated by ligands. Activation of PPARγ leads to a reduction o...
<p>Cleavage of caspase-9, caspase-3, PARP and the level of Chk2 and p53 proteins in HCT116 wt, Chk2-...
<p>(a) Percentage of apoptotic (annexin V positive/propidium iodide negative, flow cytometry) HCT116...
<p>(a) Cleavage of PARP, caspase-9 and PTEN level (Western blotting), (b) changes in mitochondrial m...
Peroxisome Proliferator-Activated Receptor gamma (PPARγ) is a ligand-activated transcription factor ...
OBJECTIVE To investigate the anti-proliferative effect of rosiglitazone and its relationship to pero...
Ligands for peroxisome proliferator-activated receptor gamma (PPARγ) possess anticancer properties. ...
<p>(a) The release of cytochrome c into the cytoplasm (cytoplasmic fraction) of HCT116 cells pretrea...
[[abstract]]To determine the involvement of peroxisome proliferator-activated receptor-gamma (PPAR-g...
[[abstract]]Background-Thiazolidinediones have been reported to protect against ischemia-reperfusion...
AIM: To study the effect of rosiglitazone, which is a ligand of peroxisome proliferator-activated re...
Ligands for peroxisome proliferator-activated receptor gamma (PPAR gamma) possess anticancer propert...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
<p><b>Copyright information:</b></p><p>Taken from "PPARγ-independent induction of growth arrest and ...
Peroxisome proliferator-activated receptors (PPARs) are shown to modulate the pathological status of...
<div><p>PPARs are nuclear receptors activated by ligands. Activation of PPARγ leads to a reduction o...